切换至 "中华医学电子期刊资源库"

中华肺部疾病杂志(电子版) ›› 2017, Vol. 10 ›› Issue (04) : 415 -419. doi: 10.3877/cma.j.issn.1674-6902.2017.04.008

所属专题: 文献

论著

抑酸药对后循环急性脑梗死患者发生肺部感染的影响
王德生1, 苏庆杰1, 龙发青1, 周向东2,(), 王杰2   
  1. 1. 570311 海口,海南医学院第二附属医院神经内科
    2. 570102 海口,海南医学院第一附属医院呼吸内科
  • 收稿日期:2017-01-18 出版日期:2017-08-20
  • 通信作者: 周向东
  • 基金资助:
    国家自然科学基金资助项目(81660010); 海南省自然科学基金项目(20168305,817337); 海南省卫计委(15A200050); 海南省教育厅基金项目(hnky2016-35)

Effects of acid suppressive drugs on common complications in patients with posterior circulation acute cerebral infarction

Desheng Wang1, Qingjie Su1, Faqing Long1, Xiangdong Zhou2,(), Jie Wang2   

  1. 1. Neurology Department, The Second Affiliated Hospital of Hainan Medical College, Haikou 570311, China
    2. Department of Respiratory Diseases, The First Affiliated Hospital of Hainan Medical College, Haikou, 570102, China
  • Received:2017-01-18 Published:2017-08-20
  • Corresponding author: Xiangdong Zhou
  • About author:
    Corresponding author: Zhou Xiangdong, Email:
引用本文:

王德生, 苏庆杰, 龙发青, 周向东, 王杰. 抑酸药对后循环急性脑梗死患者发生肺部感染的影响[J]. 中华肺部疾病杂志(电子版), 2017, 10(04): 415-419.

Desheng Wang, Qingjie Su, Faqing Long, Xiangdong Zhou, Jie Wang. Effects of acid suppressive drugs on common complications in patients with posterior circulation acute cerebral infarction[J]. Chinese Journal of Lung Diseases(Electronic Edition), 2017, 10(04): 415-419.

目的

探讨抑酸药对后循环急性脑梗死患者肺部感染和急性胃黏膜病变发生的影响,及抑酸药物的合理使用。

方法

回顾性分析2010年07月至2015年12月在我院神经内科住院确诊为急性脑梗死的患者350例,年龄大于18岁,均经头颅MR检查明确为后循环急性脑梗死,所有患者均于发病48 h内入院,且入院前无发热、咳痰等肺部感染临床症状,血白细胞无明显升高或降低,肺部影像学无新发改变,且无急性胃黏膜病变的临床表现;根据入院后是否预防性使用质子泵抑制剂类抑酸药,将其分为使用抑酸药组及非使用抑酸药组,均衡性别、年龄、糖尿病史、冠心病、意识障碍、吞咽障碍、肺部疾病、高血压、慢性胃部疾病史等组间因素后,分析有无抑酸药物使用对急性脑梗死肺部感染发生率及急性胃黏膜病变发生率的影响,将数据进行统计学分析,评价抑酸药物对急性脑梗死患者的影响。

结果

350例患者平均年龄72.3岁,其中男性210例占60%,女性140例占40%;抑酸药组男性92例,女性68例,占45.7%,平均年龄73.5岁;非抑酸药组男性118例,女性72例,占54.3%,平均年龄71.2岁;350例患者中发生肺部感染94例,总的肺部感染率为26.8%,其中男性67例占71.3%,女性27例占28.7%;使用抑酸药组发生肺部感染56例,感染率35.0%,非抑酸药组肺部感染38例,感染率20.0%,两组间肺部感染发生率的差别有统计学意义;意识障碍患者中有63例发生肺部感染,占意识障碍总人数的66.3%;吞咽困难无意识障碍患者中有28例发生肺部感染,占吞咽困难总人数的44.5%;发生急性胃黏膜病变共81例,发生率为23.1%,其中抑酸药组29例,非抑酸药组52例,两组间急性胃黏膜病变发生率有统计学意义;共53例有慢性胃部疾病史,其中抑酸药组25例,发生急性胃黏膜病变5例,非抑酸药组28例,有13例发生急性胃黏膜病变,差异有统计学意义。

结论

后循环急性脑梗死患者预防性使用抑酸药会明显增加卒中后肺部感染的发生,使用抑酸药组的急性胃黏膜病变发生率低于未用药组,提示对患者进行危险分层评估后再确定是否预防性使用抑酸药,方可得到最佳效果。

Objective

To investigate the effect of acid suppressive drugs on pulmonary infection and acute gastric mucosal lesion in patients with acute cerebral infarction.

Methods

A retrospective analysis 350 cases from July 2010 to December 2015 in the Department of Neurology of our hospital, which diagnosed acute cerebral infarction patients, older than 18 years, were examined by MR examination of posterior circulation acute cerebral infarction. All the patients were admitted within 48 hours of onset, and before admission, no fever, sputum and other symptoms of pulmonary infection, obviously no increase or decrease of white blood cell, lung imaging and no new changes, and no clinical manifestations of acute gastric mucosal lesions after admission. According to whether the preventive use of proton pump inhibitors of acid inhibitory drugs, which were divided into the use of acid suppressive medication group and non use of acid suppressive drug group. The sex, age, diabetes the history of coronary heart disease, disorder of consciousness, dysphagia, lung disease, hypertension, history of chronic disease were balanced, analysis of whether the use of acid suppressive drugs on acute cerebral infarction, the incidence of pulmonary infection and acute gastric mucosal lesions. The data were statistically analyzed to evaluate the effect of acid suppression drugs on patients with acute cerebral infarction.

Results

The mean age of the 350 patients was 72.3 years, male 210 cases accounted for 60%, female 140 cases accounted for 40%. There were 92 male and 68 female patients in the anti acid group, accounting for 45.7%, with an average age of 73.5 years. There were 118 males and 72 females in non acid drug group, accounting for 54.3%, with an average age of 71.2 years. 94 cases had pulmonary infection, and the total infection rate was 26.8% in all of the 350 patients; Male 67 cases accounted for 71.3%, Female 27 cases accounted for 28.7%; There were 56 cases of pulmonary infection in acid suppressive group, the infection rate was 35%, 38 cases of lung infection in the non acid drug group, the infection rate was 20%; The incidence of pulmonary infection between the two groups was statistically significant. There were 63 cases of pulmonary infection in patients with consciousness disorder, accounting for 66.3%. 28 patients with dysphagia had pulmonary infection, accounting for about 44.5%. There were 81 cases of acute gastric mucosal lesions, the incidence of which was about 23.1%, of which there were acid suppression group (n=29) and non acid suppression group (n=52). There was statistical significance between the two groups. A total of 53 patients had a history of chronic gastric diseases, among which, there were 25 cases of anti acid drugs, and 5 cases of acute gastric mucosal lesions occurred; There were 28 cases of non acid drug group, and 13 cases of acute gastric mucosal lesions; The difference was statistically significant.

Conclusions

The use of acid suppressive drugs will obviously increase after the cycle of pulmonary infection in acute cerebral infarction patients with acute gastric mucosal lesions, acid suppression drug group was lower than the control group. The patients were evaluated by the risk stratification, and then the best results were obtained by the use of acid suppressing drugs.

表1 两组患者组间各因素对比
1
Vermeij FH, Scholte op Reimer WJ, De Man P, et al. Stroke-associated infection is an independent risk factor for poor outcome after acute ischemic stroke: data from the Netherlands Stroke Survey[J]. Cerebrovasc Dis, 2009, 27(5): 465-471.
2
Hilker R, Poetter C, Findeisen N, et al. Nosocomial pneumonia after acute stroke: implications for neurological intensive care medicine[J]. Stroke, 2003, 34(4): 975-981.
3
Ingeman A, Andersen G, Hundborg HH, et al. In-hospital medical complications, length of stay, and mortality among stroke unit patients[J]. Stroke, 2011, 42(11): 3214-3218.
4
Finlayson O, Kapral M, Hall R, et al. Risk factors, inpatient care, and outcomes of pneumonia after ischemic stroke[J]. Neurology, 2011, 77(14): 1338-1345.
5
Smith CJ, Kishore AK, Vail A, et al. Diagnosis of stroke-associated pneumonia: recommendations from the pneumonia in stroke consensus group[J]. Stroke, 2015, 46(8): 2335-2340.
6
Metheny NA. Risk factors for aspiration[J]. JPEN J Parenter Enteral Nutr, 2002, 26(6 suppl): s26-s31.
7
Ovbiagele B, Hills NK, Saver JL, et al. Frequency and determinants of pneumonia and urinary tract infection during stroke hospitalization[J]. J Stroke Cerebrovasc Dis, 2006, 15(5): 209-213.
8
Emsley HC, Hopkins SJ. Acute ischaemic stroke and infection: recent and emerging concepts[J]. Lancet Neurol, 2008, 7(4): 341-353.
9
Haeusler KG, Schmidt WU, Föhring F, et al. Cellular immunodepression preceding infectious complications after acute ischemic stroke in humans[J]. Cerebrovasc Dis, 2007, 25(1-2): 50-58.
10
郑磊,郭红梅. 晚发的卒中相关性肺炎39例临床分析[J]. 安徽医药,2013, 17(1): 85-87.
11
刘晓玲,李静燕,张鹏,等. 围手术期质子泵抑制剂预防应激性溃疡用药分析[J]. 实用药物与临床,2015, 18(4): 496-499.
12
Herzig SJ, Howell MD, Ngo LH, et al. Acid-suppressive medication use and the risk for hospital-acquired pneumonia[J]. Jama, 2009, 301(20): 2120-2128.
13
Thorens J, Froehlich F, Schwizer W, et al. Bacterial overgrowth during treatment with omeprazole compared with cimetidine: a prospective randomised double blind study[J]. Gut, 1996, 39(1): 54-59.
14
Aybay C, Imir T, Okur H. The effect of omeprazole on human natural killer cell activity[J]. Gen Pharmac, 1995, 26(6): 1416-1418.
15
陈钊成,吴海桂,林伟明,等. 卒中相关性肺炎病原茵及耐药性分析[J/CD]. 中华肺部疾病杂志(电子版), 2015, 8(3): 348-350.
16
Alkim H, Unal S, Okur H, et al. Omeprazole inhibits natural killer cell functions [J]. Dig Dis Sci, 2008, 53(2): 347-351.
17
Laheij RJ, Sturkenboom MC, Hassing RJ, et al. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs[J]. Jama, 2004, 292(16): 1955-1960.
18
Chen CH, Lin HC, Lin HL, et al. Proton pump inhibitor usage and the associated risk of pneumonia in patients with chronic kidney disease[J]. J Microbiol Immunol Infect, 2015, 48(4): 390-396.
19
Ho SW, Tsai MC, Teng YH, et al. Population-based cohort study on the risk of pneumonia in patients with non-traumatic intracranial haemorrhage who use proton pump inhibitors[J]. BMJ open, 2014, 4(11): e006710.
20
Ho SW, Hsieh MJ, Yang SF, et al. Risk of stroke-associated pneumonia with acid-suppressive drugs: A population-based cohort study[J]. Medicine, 2015, 94(29): e1227.
21
柏愚,李延青,任旭,等. 应激性溃疡防治专家建议(2015版)[J]. 中华医学杂志,2015, 95(20): 1155-1157.
22
赵玉沛. 应激性黏膜病变预防与治疗-中国普通外科专家共识(2015)[J]. 中国实用外科杂志,2015, 35(7): 728-730.
23
Cuillamondegui OD, Cunter OI, Bonadies J, et al. Practice management guidelines for stress ulcer prophylaxis[J]. Chicago, IL:Eastern Association for the Surgery of Trauma, 2008: 1-24.
[1] 陈经欣, 李梅, 陈洁雅. 肺结节胸腔镜术后肺部感染危险因素分析[J]. 中华实验和临床感染病杂志(电子版), 2023, 17(04): 238-243.
[2] 林亚丽, 朱丹, 李云霞, 刘晓芳. 慢性呼吸衰竭合并肺部念珠菌感染的临床特征及影响因素[J]. 中华实验和临床感染病杂志(电子版), 2022, 16(06): 385-390.
[3] 周杉京, 诸葛金科, 王芳芳. 补肺活血胶囊对COPD患者cCor、ALD、Ang-Ⅱ的影响[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 517-519.
[4] 王庆, 张红联, 吴志勇. COPD合并多重耐药菌肺部感染预后危险因素分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 557-559.
[5] 刘玲, 肖颖, 王蓉. 严重创伤并发肺部感染死亡病例分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 581-583.
[6] 张晓娟, 邓祥瑞, 陈睿, 钟文. AECOPD伴肺部感染吸入三联疗效与EOS相关性分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(03): 364-366.
[7] 张沥, 宋俊华, 何皓, 杨雪瑶, 周康. 血清D-D、PAI-1、sICAM-1水平与糖尿病合并肺部感染病情严重程度及预后的关系[J]. 中华肺部疾病杂志(电子版), 2023, 16(02): 203-205.
[8] 叶晓芳, 杨京华, 武元星, 朱光发. COPD患者冠状动脉旁路移植术后肺部感染的预后影响及危险因素分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(02): 175-179.
[9] 梁华, 黄承军, 鄂桂香, 李静. 胸腺肽多索茶碱治疗COPD并发肺部感染的临床分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(02): 218-220.
[10] 崔立慧, 李士荣, 李素娟, 孙娴静, 张馨怡. 糖尿病患者肺部感染超敏C反应蛋白和降钙素原检测的临床意义[J]. 中华肺部疾病杂志(电子版), 2023, 16(01): 95-97.
[11] 汪玲玲, 申潇竹, 贾嵘, 包勤文. CRP/AIb、NLR及CD64%对老年肺部感染预后的意义[J]. 中华肺部疾病杂志(电子版), 2022, 15(06): 859-862.
[12] 孙骥, 刘牧野, 戈国亮, 彭薇, 戴梅. NLR、IL-6及C反应蛋白水平对涂阳肺结核患者继发肺部感染的预测意义[J]. 中华肺部疾病杂志(电子版), 2022, 15(05): 694-696.
[13] 张焱, 杨莉莉, 杨景森, 季迪, 宋彩萍. 慢性鼻窦炎FESS术后并发肺部感染危险因素分析[J]. 中华肺部疾病杂志(电子版), 2022, 15(05): 653-656.
[14] 李欢, 唐钰书, 王璇, 谢席胜. 慢性肾脏病患者肺部感染的诊治进展[J]. 中华肾病研究电子杂志, 2022, 11(05): 285-289.
[15] 张贺, 梁绍钦, 杜文杰, 刘辉, 符会涛, 朱德才. 脑出血患者气管切开并发肺部感染的预测研究[J]. 中华脑科疾病与康复杂志(电子版), 2022, 12(05): 291-297.
阅读次数
全文


摘要